Background. In September 2016, the Korean National Health Insurance Service began reimbursing infection control (IC) costs on condition that dedicated doctors and nurses for IC should be allocated in the hospital. We assessed the Impact of IC cost reimbursement policy on trends in central line-associated bloodstream infections (CLABSI).
Methods. A before-and-after study between pre-intervention (January 2016 to February 2017) and intervention (March 2017 to December 2017) periods was performed in three intensive care units (ICU) at Daegu Fatima Hospital (a 750-bed, secondary care hospital in Daegu, Republic of Korea). The number of dedicated IC nurses increased from 2 to 5 in September 2016 and a first dedicated IC doctor was allocated in March 2017 according to the IC cost reimbursement policy. The enhanced IC team visited ICUs daily and monitor and educate the implementation of CLABSI prevention bundles. The trends between pre-intervention and intervention periods were analyzed by segmented autoregression analysis of an interrupted time series.
Results. The average CLABSI rates and total central-line days in the pre-intervention and intervention periods were 3.41 and 2.34 per 1,000 catheter-days; 7,326 and 5,978 days, respectively. Autoregressive analysis revealed that the CLABSI rates per 1,000 catheter days per month in the pre-intervention and intervention periods were -0.256 (95% confidence interval (CI), −0.593, 0.081; P = 0.148) and −0.602 (95% CI, −0.935, −0.268; P = 0.008). The rates of compliance with maximal barrier precaution significantly improved from pre-intervention (55.1%) to intervention (89.4%) period (chi-square test, P < 0.001). The rates of compliance with maintenance bundles also significantly improved from pre-intervention (48.4%) to intervention (69.7%) period (chi-square test, P < 0.001) Conclusion. The reimbursement policy for IC cost accelerates the decline in CLABSI rates by increasing the number of IC professionals and improving monitoring, education and implementation of CLABSI prevention bundles.
Disclosures. Background. Guidelines suggest that among patients with candidemia, placement of an LTCVC, often needed for treatment, can proceed when "additional blood cultures show no growth" but the timeframe is not well defined. There is theoretical risk of relapsed CBSI after therapy if yeast are still circulating in the blood and adhere to the LTCVC. We sought to determine the blood culture time to detection (TTD) for candida to identify a timeframe for LTCVC insertion that would mitigate risk for relapsed CBSI.
Methods. We conducted a retrospective cohort study of all positive (+) blood cultures for Candida species (albicans, glabrata, tropicalis, parapsilosis, dubliniensis, krusei , and lusitaniae) isolated from August 1, 2013-December 31, 2017. Data were retrieved from the microbiology laboratory and the BD BACTEC™ blood culture system was used. TTD was recorded for each (+) blood culture in hours and the mean TTD was calculated by species.
Results. One hundred and twenty-eight blood cultures were (+) for Candida species. C. glabrata was the most common species isolated, followed by C. albicans and C. parapsilosis. Overall, the mean TTD was 43 hours (range 7.1-117.7 hours); 19.5% were positive within 24 hours, 67.2% within 48 hours, and 86.7% within 72 hours, and none required more than 120 hours (table) .
Conclusion. Among patients with candidemia, the majority of blood cultures were positive within 72 hours after inoculation and all were positive within 120 hours; however, among the three most common species, 16.3% required more than 72 hours. Waiting 120 hours before insertion of a LTVC should mitigate risk for relapsed CBSI Background. Bathing with pre-medicated 2% chlorhexidine gluconate (CHG) impregnated cloths is for prevention of central line associated blood stream infections (CLABSI). The use of CHG on patients outside of intensive care units has not been well studied. In our bone marrow and stem cell transplant unit (BMTU) we found compliance with CHG bathing to be lacking.
Methods. This was a quality improvement quasi-experimental pre-post intervention project to improve the use of CHG bathing for prevention of CLABSI in BMTU patients with central venous catheters (CVC). Review of CLABSI data identified high rates in BMTU compared with other units and significant numbers of Gram-positive organisms, suggesting needed increase in interventions directed at CVC maintenance.
Review of cases, identified barriers to CHG bathing compliance. Audits of compliance with CHG bathing was performed pre-intervention. Interviews of staff and patients identified key barriers to compliance, which included, education on the benefit of CHG bathing in prevention of CLABSI, education of the potential for "sticky" feeling after bathing, education of staff on benefits and risk, and patient self-bathing education. Our implementation began in July 2016, and included, patient and staff education, a patient contract for use of CHG, daily patient signatures after bathing, signage in patient rooms with bathing instructions, and improved compliance parameters.
Results. Compliance with CHG bathing pre-intervention was 81%, and post was 93%. Definitions for compliance changed as part of implementation, to include patient signature, and reasons for noncompliance. CLABSI rate for the BMTU pre-intervention was 2.2/1,000 device days in 2015, post intervention 1.0/1000 device days in 2017 for a 55% reduction in CLABSI. Figure 1 illustrates the decline in CLABSI rate over time after the intervention. No concomitant interventions were implement during this period.
Conclusion. Patients outside of the ICU are typically nonventilated, awake and capable of self-bathing. Many interventions have been implemented to decrease CLABSI; however, the need for patient engagement and education in the implementation is a critical step that needs to be addressed to ensure fidelity and success of the intervention. Saturday, October 6, 2018: 12:30 PM Background. Central line-associated bloodstream infections (CLABSI) are a known complication of central venous access. Pulmonary artery catheters (PAC) are frequently used in status 1A pre-heart transplant patients, at the top of the heart transplant waiting list. These patients often have a PAC in place for extended periods of time and are thus at risk for CLABSI. Our institution's practice includes routine PAC exchange after 21 days of use. We sought to estimate the risk of CLABSI and determine whether factors influenced infection rate.
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Pulmonary Artery Catheter Epidemiology of Risk (PACER) Study
Methods. We conducted a retrospective, descriptive study from January 2013 to December 2016 identifying characteristics of PAC use and infection rate in adult status 1A pre-heart transplant patients. Time to CLABSI was analyzed with Kaplan-Meier estimates. The effect of CLABSI on time to transplant and death were analyzed in time-dependent Cox models.
Results. We identified 61 status 1A pre-heart transplant patients with PACs during this time period with 219 PACs and 2566 line-days. Median duration of PAC was 11 days. There were 14 CLABSIs for an infection rate of 5.46/1,000 line-days (95% CI: 2.98-9.15), compared with 1.06/1,000 line-days for our institution's intensive care unit rate. Causative organisms were coagulase-negative Staphylococcus (79%), Enterobacter (7%), E. coli (7%), and Klebsiella (7%). There was a trend toward higher infection rate per 1,000 line-days with longer duration of PACs. Lines in place for 0-10 days resulted in an infection rate of 3.14 (1.02-7.32); 11-20 days with a rate of 8. 70 (3.19-18.94) ; and >20 days with a rate of 32. 61 (6.72-95.30 ). There was a trend toward higher infection rate with more concomitant non-PAC lines used (0 other lines, 4.57; 1 line, 6.21; 2 or more, 11.56). Median time to infection diagnosis from PAC placement was 29 days (23-49). Line infection was associated with shorter time to transplant (hazard ratio 2.49; P = 0.027), but no effect on mortality (hazard ratio 1.79; P = 0.355).
Conclusion. Our study demonstrated a high rate of CLABSI with PAC, with a trend toward increased risk with longer use, and presence of concomitant lines. Infection was associated with a shorter time to transplant, though not with time to death. Prolonged PAC use in the status 1A population should be revisited.
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